Clinical Trials
5
Active:0
Completed:5
Trial Phases
2 Phases
Phase 3:2
Phase 4:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 4
3 (60.0%)Phase 3
2 (40.0%)Assessment of the eFficacy, the Onset-of-Action and the Safety of Tot'héma® in Adults With Moderate Iron Deficiency Anaemia
Phase 4
Completed
- Conditions
- Anemia
- Interventions
- Drug: TOT'HEMA
- First Posted Date
- 2020-03-16
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Laboratoire Innotech International
- Target Recruit Count
- 167
- Registration Number
- NCT04309669
- Locations
- 🇫🇷
Hopital Pitié Salpétrière - Médecine Interne et Immunologie Clinique, Paris, France
Contraceptive Efficacy, Tolerance and Acceptability of a Benzalkonium Chloride Spermicide Cream In Women Aged Over 40 Years of Age
- First Posted Date
- 2017-04-05
- Last Posted Date
- 2020-02-26
- Lead Sponsor
- Laboratoire Innotech International
- Target Recruit Count
- 151
- Registration Number
- NCT03102450
- Locations
- 🇫🇷
Cabinet Gynecologie, Paris, France
🇫🇷Cabinet de Gynecologie, Écully, France
🇫🇷Cabinet Gynecologique, Strasbourg, France
Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis
Phase 3
Completed
- Conditions
- Vaginitis
- Interventions
- Drug: GYNODAKTARIN®Drug: POLYGYNAX®Drug: Placebo
- First Posted Date
- 2015-08-05
- Last Posted Date
- 2019-01-22
- Lead Sponsor
- Laboratoire Innotech International
- Target Recruit Count
- 661
- Registration Number
- NCT02515656
- Locations
- 🇨🇿
TURKOVA, Praha, Czechia
🇫🇷PERCEVAL, Lyon, France
🇷🇸MARICIC, Belgrade, Serbia
Open Study of the Efficacy of the Local Treatment With Polygynax of Bacterial and/or Mycotic Vaginitis
Phase 4
Completed
- Conditions
- Vaginitis
- Interventions
- Drug: Polygynax combinaison of polymyxin, Neomycin and Nystatin
- First Posted Date
- 2015-05-14
- Last Posted Date
- 2015-05-14
- Lead Sponsor
- Laboratoire Innotech International
- Target Recruit Count
- 169
- Registration Number
- NCT02444481
Efficacy and Safety of Diosmin 600mg Versus Placebo on Painful Symptomatology in Patients With Chronic Venous Disease of Lower Limbs
Phase 3
Completed
- Conditions
- Chronic Venous Disease of Lower Limbs
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-02-15
- Last Posted Date
- 2013-04-29
- Lead Sponsor
- Laboratoire Innotech International
- Target Recruit Count
- 378
- Registration Number
- NCT01532882
- Locations
- 🇫🇷
Dr Jean-Jérôme GUEX, Nice, France
News
No news found